ArticleBMC pediatrics2025
Global, regional, and national incidence and mortality of neonatal sepsis and other neonatal infections, 1990-2021 and predictions to 2050.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Systemic immune inflammation index and neutrophil-to-lymphocyte ratio as predictors of neonatal sepsis in low birth weight infants.BMC pediatrics · 2026Observational
- Rethinking neonatalFrontiers in immunology · 2026Article
- In silico drug discovery and molecular dynamics simulation for targeting neonatal pneumonia and bronchopulmonary dysplasia.Frontiers in chemistry · 2026Article
- Antibiotic treatment for neonatal sepsis: changing trends and future directions.Drugs in context · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundNeonatal sepsis and other neonatal infections (NSNI) have been long-standing global health challenges, significantly impacting child mortality. This study aims to analyze trends in age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) of NSNI at global, regional, and national levels, and to predict future ASIR trends across different Socio-demographic Index (SDI) regions using ARIMA modeling, to inform strategies for NSNI prevention and treatment.
methodsData from the 2021 Global Burden of Disease (GBD) study were used to estimate global, regional, and national trends in NSNI-related ASIR and ASMR from 1990 to 2021, and to predict future trends (2022–2050) using the autoregressive integrated moving average (ARIMA) model based on historical data.
resultsBetween 1990 and 2021, global ASIR and ASMR for NSNI declined at an average annual rate of 0.75%. Cumulatively, ASIR and ASMR decreased by 20.61% and 21.19%, respectively. All five SDI regions experienced declining trends in both ASIR and ASMR, with the greatest annual reduction in ASIR seen in low SDI regions, and the largest reduction in ASMR in high SDI regions. In 2021, Southern Sub-Saharan Africa recorded the highest ASIR (152.22 per 100,000), while Western Sub-Saharan Africa had the highest ASMR (8.55 per 100,000). ARIMA-based predicts indicate that from 2022 to 2050, ASIR is expected to rise in low, low-middle, and high SDI regions.
conclusionWhile the global burden of NSNI has decreased in most countries and regions from 1990 to 2021, some areas still exhibit increasing trends. Ongoing epidemiological research and more robust health interventions are crucial to further reducing the global burden of neonatal sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.